CutisPharma names new CEO
This article was originally published in Scrip
Executive Summary
CutisPharma, a specialty pharmaceutical company that develops and distributes bulk drugs in kits used by pharmacists to create compounded medications, has promoted president Dr Neal Muni to CEO. Dr Neal Muni replaces Dr Indu Muni who founded CutisPharma in 1998. Dr Indu Muni will remain at the company as chair of the board.